EU Calls For Suspension Of J&J's Ionsys
Law360 (November 20, 2008, 12:00 AM EST) -- In a blow to Johnson & Johnson, the European Union's drug-regulating body has recommended suspending approval for the sale of Ionsys in Europe because of a defect with the pain medicine's...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
